- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06261463
Pilot Trial of a Peer-led Family and Social Strengthening Group Intervention for Refugee Families
Leveraging Implementation Science and Design Methods to Sustain Community-based Mental Health Services for Refugees
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In partnership with refugee service organizations in Chicago, the investigator explored the problems, strengths, and help-seeking preferences of refugee families. Qualitative findings indicated ongoing problems coping with stress, trauma and loss, strain and tension in family relationships and limited social support networks. Families identified a need for family-focused, group-based services led by individuals with similar life experiences. Based on these findings, we identified an evidence-based multiple-family group model, Coffee and Family Education and Support (CAFES) as a foundational model that could be adapted to meet the needs of refugee families. Drawing on this formative work and strong community partnerships, further research is needed to adapt CAFES to a new population, to reflect multi-level needs of families and for use by refugee peer facilitators in community-based organizations. Research is also needed to assess feasibility, acceptability and fidelity of model implementation, attentive to barriers and facilitators specific to peer-led mental health services and community settings.
We will use a pilot randomized type 1 hybrid effectiveness-implementation design to achieve the following specific research aims:
Aim 1: To adapt the multiple family CAFES model for delivery by peers in community organizations using an implementation science adaptation framework and participatory human-centered design methods to develop an intervention that addresses the complex needs of refugee families.
Aim 2: To pilot the adapted CAFES2 model to examine feasibility, acceptability and provider fidelity when implemented by refugee peers in two community-based organizations in Chicago. (n=74, 37 intervention, 37 control) Aim 3: To explore the impact of the adapted CAFES2 model compared to enhanced control on outcomes of adult and child mental health and family and community support and explore variables expected to mediate the intervention's impact.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mary Bunn, PhD
- Phone Number: (312) 355-2136
- Email: mbunn@uic.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria for Families:
- being a resettled refugee family
- having one or more school-aged children aged 12 years and older living with them
- one family member (caregiver or youth) screens for moderate emotional distress
Inclusion Criteria for Adult Caregivers/Parents:
- between ages of 18-45 years old
- arrived to the U.S as a refugee
- have at least one child currently living with them
Inclusion Criteria for Youth:
- between ages of 12 and 17 years old)
- arrived as a refugee
- currently living with at least one caregiver.
Exclusion Criteria:
- not meeting the above inclusion criteria
- families or individual in the midst of a crisis (e.g. family crisis or mental health crisis)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CAFES2 family and social strengthening intervention
Families randomized into CAFES2 receive a home visit and participate in six multiple family group sessions in addition to any outside services or programs they are participating in.
|
The adapted CAFES2 model includes an initial home visit and six multiple family group sessions delivered by peer providers.
Families include at least one caregiver and one youth 12 years or older.
Key model components include: 1) interfamilial discussion of stressors affecting families and family relationships, 2) psychoeducation on the effects of war and forced displacement on individuals, families and social relationships; 3) emotion regulation and self management strategies; 4) identification and activation of family and social strengths, 5) discussion of family identity and hopes for the future in resettlement and 5) discussion of social and community resources to support health and wellbeing.
Each group session incorporates didactic components, family and small group discussion, skill building and separate breakout groups for adolescents and adults.
Other Names:
|
No Intervention: Enhanced Control
Families randomized to the enhanced control arm will not receive the CAFES2 intervention Instead, they will continue with their usual care, and also receive healthy lifestyle materials.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in PTSD symptoms via the PTSD Checklist (adult, exploratory)
Time Frame: baseline, immediate post-intervention and 6-week follow up
|
PTSD Checklist utilizes a 5-point likert scale (0-4) to assess post traumatic stress symptoms.
Higher scores indicate increasing levels of PTSD.
|
baseline, immediate post-intervention and 6-week follow up
|
Changes in adult depression and anxiety via the Hopkins Symptom Checklist (HSCL, adult, exploratory)
Time Frame: baseline, immediate post-intervention and 6-week follow up
|
HSCL measures symptoms of anxiety and depression in adults using a 4-point likert scale (1-4) with high scores indicating higher levels of anxiety and depression symptoms.
|
baseline, immediate post-intervention and 6-week follow up
|
Changes in youth depression and anxiety via the Hospital Anxiety and Depression Scale (HADS, youth, exploratory)
Time Frame: baseline, immediate post-intervention and 6-week follow up
|
HADS measures symptoms of anxiety and depression in youth using a 4-point likert scale (0-3).
Total scores are associated with mild, moderate or severe anxiety or depression.
|
baseline, immediate post-intervention and 6-week follow up
|
Changes in PTSD in children and youth via the Child Revised Impacted of Events Scale (CRIES, youth, exploratory)
Time Frame: baseline, immediate post-intervention and 6-week follow up
|
CRIES is a measures to assess PTSD symptoms in children and youth.
Higher total scores indicate higher PTSD symptoms.
|
baseline, immediate post-intervention and 6-week follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in social support via the Medical Outcomes Study Social Support Survey
Time Frame: baseline, immediate post-intervention and 6-week follow up
|
This measure assesses diverse forms of social support using a 5-point likert scale.
Higher overall scores indicate greater degree of available support.
|
baseline, immediate post-intervention and 6-week follow up
|
Changes in social interaction via the Duke Social Support Index, social interaction subscale
Time Frame: baseline, immediate post-intervention and 6-week follow up
|
The Duke Social Support Index, social interaction subscale assesses diverse types of daily social interactions.
Higher scores indicate greater degrees of social interaction.
|
baseline, immediate post-intervention and 6-week follow up
|
Changes in parenting via the Alabama Parenting Questionnaire (adult and youth)
Time Frame: baseline, immediate post-intervention and 6-week follow up
|
Likert scale (1-5) that includes 5 sub-domains.
Each sub-domain results in a summed score that relates to 5 domains of parenting: involvement, positive parenting, poor monitoring/supervision, inconsistent discipline, and corporal punishment.
|
baseline, immediate post-intervention and 6-week follow up
|
Changes in family communication via the Family Problem Solving Communication Scale
Time Frame: baseline, immediate post-intervention and 6-week follow up
|
The Family Problem Solving Communication Scale assess family communication style using a 4-point likert scale with higher scores indicating greater degrees of problem-oriented communication.
|
baseline, immediate post-intervention and 6-week follow up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in acceptability of the intervention via the Johns Hopkins University Dissemination and Implementation Science Measure
Time Frame: baseline, immediate post-intervention
|
This measure assess the degree to which the intervention is viewed as agreeable or satisfactory
|
baseline, immediate post-intervention
|
Changes in feasibility of the intervention via the Johns Hopkins University Dissemination and Implementation Science Measure
Time Frame: baseline, immediate post-intervention
|
This measure assesses the degree to which a given intervention is viewed as feasible for a given population and setting.
Higher scores are associated with greater degrees of perceived feasibility.
|
baseline, immediate post-intervention
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Mary Bunn, PhD, University of Illinois Chicago
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-0326
- K01MH128524-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States